Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China flag China · Delayed Price · Currency is CNY
5.43
+0.02 (0.37%)
Feb 3, 2026, 3:00 PM CST

SHA:600713 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,6924,5632,3722,3282,0951,482
Cash & Short-Term Investments
1,9834,5632,3722,3282,0951,482
Cash Growth
71.05%92.39%1.87%11.13%41.32%-29.52%
Accounts Receivable
20,28515,09816,20919,30415,25114,262
Other Receivables
947.897.929.7129.2822.8627.39
Receivables
21,23215,19616,23819,33415,27414,289
Inventory
6,6086,2865,7985,7874,5184,065
Other Current Assets
1,1801,7641,6051,8131,5711,328
Total Current Assets
31,00327,80826,01329,26123,45821,165
Property, Plant & Equipment
2,0491,8851,5071,5191,4921,187
Long-Term Investments
277.91283.47237.64206.45254.18324.12
Goodwill
72.1772.1772.1772.1772.1774.17
Other Intangible Assets
204.56215.68218.98245.28268.11282.17
Long-Term Deferred Tax Assets
264.87243.43222.82224.93180.78185.92
Long-Term Deferred Charges
85.1963.0743.3436.8934.2452.76
Other Long-Term Assets
87.97102.7495.5884.69126.24138.93
Total Assets
34,04530,67428,41031,65125,88623,410
Accounts Payable
10,13510,1769,69410,1318,0647,634
Accrued Expenses
133.75369.49363.63438.32379.33315.11
Short-Term Debt
8,1263,7604,5748,4147,0367,642
Current Portion of Long-Term Debt
287.28900.982,2231,409--
Current Portion of Leases
-79.6376.0471.6878.281.04
Current Income Taxes Payable
17987.691.48102.89136.01108.7
Current Unearned Revenue
268.64278.67103.57219.1274.7875.24
Other Current Liabilities
2,3161,4411,4411,4981,7561,427
Total Current Liabilities
21,44617,09418,56622,28417,52517,203
Long-Term Debt
4,1215,3392,1182,2222,6281,027
Long-Term Leases
190.86116.18119.02103.23124.42.51
Long-Term Unearned Revenue
266.96277.62297.06293.17304.61265.33
Long-Term Deferred Tax Liabilities
62.6959.0555.4154.2469.992.1
Total Liabilities
26,08722,88621,15524,95620,65218,589
Common Stock
1,3091,3091,3101,3101,0421,042
Additional Paid-In Capital
2,4542,4662,4602,4291,3801,652
Retained Earnings
3,1522,9732,6112,2171,7781,388
Treasury Stock
-48.34-20.9-35.9-38.58--
Comprehensive Income & Other
106.96111.2489.7281.98406.6176.6
Total Common Equity
6,9746,8386,4356,0004,6064,258
Minority Interest
984.06949.87819.73695.03627.46562.59
Shareholders' Equity
7,9587,7887,2556,6955,2344,820
Total Liabilities & Equity
34,04530,67428,41031,65125,88623,410
Total Debt
12,72510,1969,11012,2199,8678,673
Net Cash (Debt)
-10,742-5,634-6,738-9,891-7,772-7,190
Net Cash Per Share
-7.65-4.32-5.19-7.89-7.46-6.90
Filing Date Shares Outstanding
1,3091,3091,3101,3101,0421,042
Total Common Shares Outstanding
1,3091,3091,3101,3101,0421,042
Working Capital
9,55810,7147,4476,9785,9333,962
Book Value Per Share
5.335.224.914.584.424.09
Tangible Book Value
6,6976,5506,1445,6824,2663,901
Tangible Book Value Per Share
5.125.004.694.344.103.75
Buildings
-1,4631,1331,1661,046-
Machinery
-928.24890.32839.29762.13-
Construction In Progress
-237.27130.0880.23153.4-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.